Template:Cefpirome: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
(2 intermediate revisions by the same user not shown)
Line 5: Line 5:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome compositiion|Composition]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome compositiion|Composition]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome properties|Properties]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome properties|Properties]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome indications|Indications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome microbiology|Microbiology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome microbiology|Microbiology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome indications and usage|Indications and Usage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome contraindications|Contraindications]]
Line 22: Line 19:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome drug interactions|Drug Interactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome drug interactions|Drug Interactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome how supplied|How Supplied]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome labels and packages|Labels and Packages]]
|-
|-
|}
|}

Latest revision as of 18:54, 2 January 2014